H. pylori does not appear to cause GERD in most people. A large body of evidence points in the opposite direction: infection with this stomach bacterium is linked to a lower risk of gastroesophageal reflux disease, and getting rid of it can sometimes trigger new reflux symptoms. That said, the relationship is genuinely complicated, shaped by the specific bacterial strain involved, where in the stomach it sets up camp, and even the population being studied. The story is not as simple as “good bacterium” or “bad bacterium.”
How H. Pylori Alters Acid Production
To understand why H. pylori might protect against reflux, you need to know what it does to stomach acid. When H. pylori colonizes the antrum (the lower portion of the stomach near the intestine), it triggers increased release of gastrin, a hormone that stimulates acid production. That sounds like it should make reflux worse. But there is a twist. The infection also reduces the number of somatostatin-producing cells in the antrum, which are the cells that normally put the brakes on gastrin release.1The Korean Journal of Internal Medicine. Effect of Helicobacter pylori infection on antral gastrin and somatostatin cells and on serum gastrin concentrations The net effect depends on where the infection spreads. If H. pylori colonizes just the antrum, acid output tends to go up, which may predispose someone to duodenal ulcers. But when the infection spreads to the body of the stomach (a pattern called pangastritis), it damages the acid-producing glands themselves, and total acid output actually drops.
That drop in acid is the key mechanism behind the apparent protective effect. People with widespread H. pylori infection and reduced acid secretion simply have less acid available to reflux into the esophagus. Strains carrying the CagA virulence factor are more likely to cause this kind of widespread inflammation, which is why CagA-positive infections are associated with less severe GERD and less esophageal damage.2PubMed Central. Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship? Additionally, during H. pylori infection, the inflammatory cytokine IL-1β is expressed at high levels, and this molecule itself inhibits gastric acid secretion.3PubMed. IL-1β, an important cytokine affecting Helicobacter pylori-mediated gastric carcinogenesis
What Happens When You Eradicate H. Pylori
If the bacterium was suppressing acid, you would expect that killing it off might bring acid levels back up and potentially cause reflux. That is exactly what researchers have observed. A meta-analysis pooling data from 18 cohort studies and three randomized controlled trials found that GERD risk roughly doubled after H. pylori eradication.4PubMed Central. Helicobacter pylori Infection and Eradication in Relation to Gastroesophageal Reflux Disease The risk was even higher when researchers looked specifically at reflux esophagitis (visible damage to the esophageal lining) rather than just reflux symptoms.
In Japan, where eradication therapy has been widely adopted, reflux esophagitis develops in roughly one in ten patients after successful treatment.5PubMed Central. Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese? This does not mean doctors should avoid eradication. H. pylori causes stomach ulcers, gastritis, and gastric cancer, and treating it is the right call in most clinical situations. But the post-eradication reflux phenomenon is real enough that clinicians in high-prevalence countries watch for it. When someone is treated for H. pylori and then develops new heartburn, the connection is not just coincidence.
Eradication also affects gastrin levels. The elevated gastrin that H. pylori infection causes tends to fall after successful treatment, confirming that the hormonal disruption is directly tied to the bacterium’s presence in the stomach.6PubMed Central. Antral Helicobacter pylori infection, hypergastrinemia and peptic ulcers: effect of eradicating the organism
Why the Answer Differs Between Asia and the West
One of the more confusing aspects of this topic is that the data looks different depending on where you are. In Asian countries, where H. pylori prevalence has historically been very high, eradication therapy is more clearly linked to new GERD cases. In Western countries, the connection is murkier. Some Western studies show no significant increase in GERD after eradication.7PubMed Central. Helicobacter pylori Infection in Gastroesophageal Reflux Disease in the Asian Countries
Several factors probably explain this gap. H. pylori strains in East Asia are more likely to carry the CagA gene (and East Asian CagA variants are biologically more active than Western ones), so the acid-suppressing effect may be stronger in those populations. Dietary patterns, body composition, and rates of obesity also differ. In Western countries, the high background rate of GERD from obesity and diet may overwhelm whatever modest protective effect H. pylori provides, making the signal harder to detect in studies. Subgroup analyses in some meta-analyses have shown a stronger post-eradication GERD effect in Asian populations, though not all analyses find a statistically significant difference when they separate the groups.8Journal of Translational Gastroenterology. Impact of Helicobacter pylori Status on GERD, Barrett’s Esophagus and Esophageal Cancer
The Lower Esophageal Sphincter Is Probably Not Involved
A reasonable hypothesis might be that H. pylori affects the lower esophageal sphincter, the muscular valve that prevents stomach contents from flowing back up. If infection strengthened the sphincter, or if eradication weakened it, that could explain reflux patterns. Researchers have tested this directly, and the answer appears to be no. One study measured sphincter pressure and the rate of transient sphincter relaxations (the main mechanical cause of reflux episodes) in infected and uninfected people and found no significant differences between the groups.9PubMed. H. pylori and transient lower esophageal sphincter relaxations induced by gastric distension in healthy humans The same research found that even though H. pylori infection increased inflammatory markers in the stomach lining, those markers did not correlate with sphincter behavior.
Another single-center study that grouped patients by sphincter function found no significant relationship between H. pylori status, sphincter pressure disorders, and the presence of reflux or reflux esophagitis.10PubMed Central. Relationship Among Helicobacter Pylori, Lower Esophagus Sphincter Pressure, and Gastroesophageal Reflux: A Single-Center Experience The sphincter, in other words, seems to do its own thing regardless of whether H. pylori is present. The bacterium’s influence on reflux operates through acid chemistry, not through changes in the mechanical valve.
Gastric Motility and Delayed Emptying
There is another wrinkle. H. pylori infection can slow down how fast your stomach empties its contents, a condition called delayed gastric emptying. Animal research has shown that infection reduces the number of specialized pacemaker cells in the stomach wall, which coordinate the muscular contractions that push food toward the small intestine.11PubMed Central. Helicobacter pylori causes delayed gastric emptying by decreasing interstitial cells of Cajal In theory, a stomach that holds food longer generates more distension and more opportunities for reflux episodes. This could be one pathway through which H. pylori might promote reflux in some individuals, counteracting the acid-lowering effect.
Interestingly, when researchers compared gastric emptying times in patients who received H. pylori treatment against those who did not, the treated group had faster emptying.12PubMed Central. Changes in patients’ symptoms and gastric emptying after Helicobacter pylori treatment So eradication may improve motility while simultaneously removing the acid-suppression effect. These two changes push in opposite directions when it comes to reflux risk, which helps explain why the net outcome of eradication varies from person to person.
Children May Be Different
Most of the protective-effect data comes from adult populations, and there is at least one study in children that found the opposite pattern. A pediatric study reported that H. pylori-positive children were significantly more likely to have reflux esophagitis than H. pylori-negative children. Among children aged one to ten, every single H. pylori-positive child in the study had reflux esophagitis, compared with fewer than half of those without the infection. On multivariate analysis, infected children had nearly six times the odds of having reflux esophagitis.13PubMed Central. Positive Association between Helicobacter pylori and Gastroesophageal Reflux Disease in Children
This is a single study, and it would be a mistake to draw broad conclusions from it alone. But it raises the possibility that the relationship between H. pylori and reflux is not the same across all ages. In children, the infection may not have had time to cause the widespread gastric atrophy that reduces acid output in adults. Instead, the antral-predominant pattern (which tends to increase acid) may dominate, potentially worsening reflux rather than preventing it. More pediatric research is needed before anyone can say this confidently, but it is a reminder that adult findings do not automatically apply to younger patients.
The Connection to Barrett’s Esophagus and Esophageal Cancer
If H. pylori protects against reflux, it should also protect against the downstream consequences of chronic reflux, including Barrett’s esophagus (a precancerous change in the esophageal lining) and esophageal adenocarcinoma. The data supports this. A community-based study found that people with Barrett’s esophagus were substantially less likely to carry H. pylori antibodies. Among those with CagA-positive strains, the inverse association was dramatically strong.14PubMed Central. Helicobacter Pylori Infection and the Risk of Barrett’s Oesophagus: A Community-Based Study
For esophageal adenocarcinoma specifically, a meta-analysis found that H. pylori infection was associated with a meaningfully lower cancer risk overall, and that this protection was concentrated in CagA-positive infections. CagA-negative strains showed no such protective effect.15PubMed Central. Helicobacter pylori and esophageal cancer risk: a meta-analysis Other meta-analyses of observational studies have reached similar conclusions, consistently finding an inverse association between CagA-positive H. pylori and esophageal adenocarcinoma.16PubMed Central. Helicobacter pylori infection and esophageal adenocarcinoma: a review and a personal view This is part of a striking epidemiological pattern: as H. pylori prevalence has declined in Western countries over recent decades, rates of esophageal adenocarcinoma have climbed, while the type of gastric cancer associated with H. pylori has fallen.17Journal of Clinical Gastroenterology. DIVERGING TRENDS IN THE INCIDENCE OF REFLUX-RELATED AND HELICOBACTER PYLORI-RELATED GASTRIC CARDIA CANCER
The implication is uncomfortable: eliminating a bacterium that causes stomach cancer may inadvertently increase the risk of a different cancer further up the digestive tract. Nobody is arguing against treating H. pylori when it causes ulcers or gastric cancer risk, but the tradeoff is real at a population level.
Not All Strains Are Created Equal
Throughout this discussion, the CagA gene keeps coming up. CagA-positive H. pylori strains produce a protein that gets injected directly into the cells lining the stomach, triggering more intense inflammation and a stronger immune response. Paradoxically, while this makes CagA-positive strains more dangerous in terms of stomach ulcers and gastric cancer, it also makes them more protective against esophageal disease.18PubMed Central. Helicobacter pylori in esophageal carcinogenesis: Potential culprit or forceful defender? The reason ties back to the acid mechanism: CagA-positive strains cause more extensive gastric inflammation and more acid suppression.
CagA-negative strains, by contrast, tend to cause milder, more localized infections. They do not suppress acid as effectively, and they show no significant protective association with esophageal adenocarcinoma. This means that not every H. pylori infection is relevant to the GERD question. If you are infected with a CagA-negative strain, the bacterium is likely not doing much to your reflux risk in either direction.
Weight Gain After Eradication
One underappreciated factor in post-eradication GERD is weight gain. After successful H. pylori treatment, many patients gain weight, and obesity is one of the strongest risk factors for reflux. Research has shown that changes in plasma ghrelin (a hunger-stimulating hormone) after H. pylori eradication are inversely correlated with body weight changes.19PubMed. Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure In plainer terms, the hormonal shifts that follow eradication may increase appetite and contribute to weight gain, which then raises reflux risk through a completely separate pathway involving abdominal pressure on the stomach.
This means that some of the increased GERD seen after eradication may not be due to the return of gastric acid at all. It may be partly a downstream consequence of metabolic changes and weight gain. For people who already have reflux risk factors like obesity, eradication could compound the problem from multiple angles.
Practical Testing Complications
If you are dealing with both GERD and suspected H. pylori, there is a practical headache worth knowing about. Proton pump inhibitors (PPIs), the most common medications for reflux, can interfere with H. pylori testing. In one study, about a third of patients on PPI therapy developed transiently false-negative urea breath test results because the drugs reduced H. pylori density in the stomach to levels below the test’s detection threshold.20PubMed. Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors The bacteria were still there; the test just could not find them. Results returned to positive within about two weeks of stopping the PPI. Standard clinical guidelines recommend stopping PPIs at least two weeks before breath testing for this reason, but not every patient or clinician follows this protocol, which can lead to missed diagnoses.
There is also a longer-term concern with PPIs in H. pylori-infected patients. Animal research has shown that prolonged PPI use in the presence of H. pylori infection worsens atrophy in the body of the stomach and promotes precancerous changes.21PubMed. Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori This is one reason some gastroenterologists recommend testing for and treating H. pylori before starting a patient on long-term PPI therapy.
A Bacterium That Has Been With Us for Millennia
H. pylori has colonized humans for at least 50,000 years, and very likely for as long as our species has existed.22PubMed Central. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications For most of human history, virtually everyone carried it. The bacterium co-evolved with us, and our immune and digestive systems developed in an environment where H. pylori was always present. Its rapid disappearance from affluent populations over the past century, driven by improved sanitation and widespread antibiotic use, is an evolutionary novelty, and some researchers have argued that this sudden absence is itself a cause of new disease patterns.23Gut and Liver. Evolutionary History of the Helicobacter pylori Genome: Implications for Gastric Carcinogenesis
The parallel rise in GERD, Barrett’s esophagus, esophageal adenocarcinoma, and certain allergic and autoimmune conditions in countries where H. pylori is vanishing fits neatly into this framework. The bacterium is not harmless, given that it is a definitive cause of stomach ulcers and gastric cancer, but framing it purely as a pathogen misses the larger picture. In most people who carry it, H. pylori lives as a commensal organism that modulates the stomach’s chemical environment without ever causing obvious disease. Its loss may be trading one set of health problems for another, and the rise of GERD in developed nations could be one part of that exchange.